A Phase II Clinical Study of Rituximab and High-Dose Biweekly THP-COP (Pirarubicin, Cyclophosphamide, Vincristine and Predonisolone) with G-CSF for Non-Hodgkin Lymphoma: Results of a Multicentric Study of NMLSG (Niigata Malignant Lymphoma Study Group).
| Autor: | Takizawa, Jun *, Aoki, Sadao, Takai, Kazue *, Kurasaki, Tohri *, Honma, Keiichiro *, Higashimura, Masutaka *, Nagai, Kouichi *, Momoi, Akihito *, Nikkuni, Koji, Aizawa, Yoshufusa * |
|---|---|
| Zdroj: | In Blood 16 November 2005 106(11):4734-4734 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|